Board Changes

EKF Diagnostics Holdings PLC

27 April 2026

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Board Changes

Appointment of Chief Financial Officer

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-quoted global diagnostics business, announces the appointment of Helen Jones FCA as Chief Financial Officer ("CFO"). Helen will join the Board and assume the role of CFO with immediate effect.

Helen Jones is an experienced CFO with over 20 years' experience leading finance, operations, and strategic transactions in high-growth, technology-driven AIM listed businesses.

Helen joins EKF from Surgical Science, a leading provider of medical simulation solutions, where she has assumed a senior Group-level role following its acquisition of Intelligent Ultrasound Group plc in February 2025, with responsibility spanning post-acquisition integration and operational cost reduction, Group statutory reporting, and sustainability leadership. Prior to the acquisition, Helen spent five years as CFO of Intelligent Ultrasound Group plc, an AIM-listed company supplying simulation and AI-based ultrasound training solutions to the healthcare sector. During her tenure, Helen led two successful equity placings to fund growth and innovation, played a central role in both the £40.6 million divestment of its Clinical AI division to GE Healthcare and the subsequent sale of the Simulation business to Surgical Science.

Before joining Intelligent Ultrasound, Helen held a senior finance role within AIM-listed oil and exploration company Amerisur Resources plc and prior to that spent 11 years in various senior financial positions at Tata Steel Europe. Helen is a fellow of the Institute of Chartered Accountants in England and Wales having trained and qualified with PwC in 2004.

Helen succeeds Stephen Young, who is retiring from the Board. Steve will be available to support Helen to ensure a smooth handover but will step down from the Board with immediate effect. The Board would like to extend its sincere thanks to Steve for his financial stewardship since joining the Company in September 2023 and wishes him well in his retirement.

Commenting, Gavin Jones, Chief Executive Officer, said: "We are delighted to welcome Helen to the EKF team at a key time as we execute on our five-year development plan for accelerated growth. Helen's track record in listed healthcare technology businesses, her experience executing complex transactions, and her capital markets expertise make her an excellent fit for EKF as we accelerate our five-year plan. Her appointment reflects our commitment to building a leadership team capable of delivering our ambitious growth targets."

Additional Disclosures Required under the AIM Rules for Companies

The following additional information is provided with regards to the appointment of Helen Mary Kinsey Jones (aged 47) in accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

Current Directorships/partnerships	Directorships/partnerships within the last five years:
None	IML Finance Limited
	Intelligent Ultrasound Innovations Limited
	Intelligent Ultrasound Limited
	Intelligent Ultrasound North America Inc
	Inventive Medical Limited
	Medaphor International Limited
	Surgical Science UK Limited
	Surgical Science UK Holdings Limited

Helen does not hold any shares or options in the Company.

There are no further disclosures required under Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

The person responsible for arranging the release of this Announcement
on behalf of the Company is Gavin Jones, Chief Executive Officer.

EKF Diagnostics Holdings plc		www.ekfdiagnostics.com
Julian Baines, Executive Chair		via Walbrook PR
Gavin Jones, Chief Executive Officer
Singer Capital Markets (Nominated Adviser & Broker)			Tel: [phone]
Phil Davies / Patrick Weaver
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Alice Woodings	Mob: [phone]

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is an AIM-listed global diagnostics business focussed on:

●	Point-of-Care analysers in the key areas of Hematology and Diabetes
●	Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

 

END